Letter to the Editor: Reduced-Dose Thrombolysis for Acute Pulmonary Embolism

Angiology. 2024 Mar;75(3):299-300. doi: 10.1177/00033197231189915. Epub 2023 Jul 24.

Authors

Adrian Rojas Murguia¹, Debabrata Mukherjee², Chandra Ojha², Manu Rajachandran², Nils P Nickel³

Affiliations

¹ Department of Internal Medicine, Health Sciences Center, Texas Tech University, El Paso, TX, USA.
² Division of Cardiovascular Medicine, Department of Internal Medicine, Health Sciences Center, Texas Tech University, El Paso, TX, USA.
³ Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Health Sciences Center, Texas Tech University, El Paso, TX, USA.

PMID: 37482804
DOI: 10.1177/00033197231189915

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Fibrinolytic Agents / adverse effects
Humans
Pulmonary Embolism* / drug therapy
Thrombolytic Therapy / adverse effects
Treatment Outcome

Substances

Fibrinolytic Agents